Acadia Pharmaceuticals buy JPMorgan Chase & Co.
Start price
29.09.25
/
50%
€18.17
Target price
29.09.26
€28.15
Performance (%)
25.54%
Price
12.01.26
€22.81
Summary
This prediction is currently active. The prediction currently has a performance of 25.54%. This prediction currently runs until 29.09.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 2.241% | 2.241% |
| iShares Core DAX® | 2.331% | 5.140% |
| iShares Nasdaq 100 | 2.077% | 2.956% |
| iShares Nikkei 225® | 2.759% | 7.214% |
| iShares S&P 500 | 1.613% | 2.893% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target lowered by analysts at JPMorgan Chase & Co. from $34.00 to $33.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.43
17.11.25
17.11.25
€26.71
17.11.26
17.11.26
10.72%
12.01.26
12.01.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
24.07.25
24.07.25
€28.88
24.07.26
24.07.26
14.05%
12.01.26
12.01.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.28
06.06.25
06.06.25
€26.22
06.06.26
06.06.26
18.31%
12.01.26
12.01.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.50
25.03.24
25.03.24
€23.06
25.03.25
25.03.25
-4.67%
26.03.25
26.03.25